Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EU Accelerated Assessment Tracker

Nov 19 2019

• By Vibha Sharma

Related Content

Keeping Track: Vertex’ Trikafta Speeds To US Approval; New Indications For AZ’s Farxiga, J&J’s Stelara, GSK’s Zejula

Oct 25 2019

Roche Takes Orphan Satralizumab To EMA

Oct 10 2019

EU Fast-Track Success For BioMarin’s Valrox But Not For Amarin’s Vascepa

Oct 25 2019

EU Accelerated Assessment – Hard To Get, Hard To Keep

Jul 19 2019

ViiV Seeks Speedy EMA Review For Last-Resort HIV Drug

Nov 14 2019

Myeloma BCMA Therapy In Spotlight: EMA Considers Fast Tracking GSK Filing

Nov 13 2019

Another Ebola Vaccine Among New Filings At EMA

Nov 08 2019

EMA OKs Seven New Drugs But Delivers Another Blow To Emmaus

Sep 20 2019

Merck’s Ervebo Becomes World’s First Approved Ebola Vaccine

Nov 12 2019

Related Companies

Johnson & Johnson

Vertex Pharmaceuticals Incorporated

Roche Holding AG

Chugai Pharmaceutical Co., Ltd.

Alnylam Pharmaceuticals Inc.

BioMarin Pharmaceutical Inc.

Merck & Co., Inc.

Astellas Pharma, Inc.

GSK plc

ViiV Healthcare

Incyte Corporation

Additional Topics

Europe Drug Review Regulation BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window